3月19日,复锐医疗科技有限公司发布了2024年全年业绩。公司全年收益达349.1百万美元,其中直销收益占比高达87%,成为公司营收的主要驱动力。从区域表现来看,亚太、欧洲、中东及非洲市场分别实现收益116.2百万美元、50.5百万美元和34.6百万美元,较去年同期分别增长6.0%、0.7%和27.1%。然而,北美市场表现不佳,收益为137.4百万美元,同比下降12.4%。公司表示,未来将继续加速...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.